FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367303702> ?p ?o ?g. }

• W4367303702 abstract "<h3>Objective:</h3> It remains unclear how the timing of in-hospital calcium channel blockers (CCBs; Nimodipine or Cardene) initiation effects the risk for vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). <h3>Background:</h3> After aSAH patients are given CCB to prevent vasospasm which is associated with worsened outcomes. <h3>Design/Methods:</h3> This retrospective cohort study included adults (≥ 18) with aSAH at a Comprehensive Stroke Center (1/18–11/21) who were taking the following prehospital antihypertensives: CCBs, Angiotensin-converting enzyme (ACE) inhibitors or Angiotensin II receptor blockers (ARBs). Comparisons were made between those who received vasospasm prevention (‘in-hospital CCBs’) ≤ 1 hour of arrival to those who received in-hospital CCBs > 1 hour from arrival. Outcomes included: vasospasm, length of stay (LOS), and death. <h3>Results:</h3> There were 252 patients, 18% were taking prehospital antihypertensives. Of those 80% received in-hospital CCBs: 35% ≤ 1 hour of arrival, 65% received them > 1 hour of arrival. Patients were similar in their baseline characteristics. The time to in-hospital CCBs was significantly longer for patients who had a vasospasm, 1.3 vs 5.2 h, p=0.02. Those who received in-hospital CCBs ≤ 1 hour of arrival experienced a significantly lower vasospasm rate (0% vs. 38%, p=0.01), LOS (11 vs 22, p=0.006), and death rate (0% vs 38%, p=0.01) than among those who did not. These results were not replicated for patients who were <i>not on prehospital antihypertensiv</i>es; the timing to in-hospital CCB initiation had no effect on vasospasm (p=0.18), death (p=0.28), or LOS (p=0.08) for patients <i>not on prehospital antihypertensives.</i> <h3>Conclusions:</h3> While larger studies are needed, this study showed that those on prehospital CCBs, ACE-inhibitors, or ARBs, receipt of in-hospital CCBs ≤ 1 hour of arrival significantly reduced the vasospasm rate, HLOS, and death rate. Reducing disruption times in prehospital antihypertensive treatment through in-hospital CCB receipt ≤ 1 hour of arrival, may prevent worsened outcomes. <b>Disclosure:</b> Donald Frei has received personal compensation in the range of $0-$499 for serving as a Consultant for Philips. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shape Memory Medical. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz.AI. Donald Frei has received stock or an ownership interest from Penumbra. Donald Frei has received research support from Penumbra. Stephanie Jarvis has nothing to disclose. Dr. Pirahanchi has nothing to disclose. Dr. DiSalvo has nothing to disclose. Mr. Wenz has nothing to disclose. David Bar-Or has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ampio Pharmaceuticals. David Bar-Or has stock in Ampio Pharmaceuticals." @default.
• W4367303702 created "2023-04-29" @default.
• W4367303702 creator A5000631035 @default.
• W4367303702 creator A5011937647 @default.
• W4367303702 creator A5026362768 @default.
• W4367303702 creator A5031497734 @default.
• W4367303702 creator A5032408299 @default.
• W4367303702 creator A5077883700 @default.
• W4367303702 date "2023-04-25" @default.
• W4367303702 modified "2023-10-18" @default.
• W4367303702 title "Decreased Timing to Vasospasm Prevention Medication Improves Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage on Prehospital CCBs, ARBs, or ACE-inhibitors (P13-7.006)" @default.
• W4367303702 doi "https://doi.org/10.1212/wnl.0000000000202542" @default.
• W4367303702 hasPublicationYear "2023" @default.
• W4367303702 type Work @default.
• W4367303702 citedByCount "0" @default.
• W4367303702 crossrefType "proceedings-article" @default.
• W4367303702 hasAuthorship W4367303702A5000631035 @default.
• W4367303702 hasAuthorship W4367303702A5011937647 @default.
• W4367303702 hasAuthorship W4367303702A5026362768 @default.
• W4367303702 hasAuthorship W4367303702A5031497734 @default.
• W4367303702 hasAuthorship W4367303702A5032408299 @default.
• W4367303702 hasAuthorship W4367303702A5077883700 @default.
• W4367303702 hasConcept C126322002 @default.
• W4367303702 hasConcept C127413603 @default.
• W4367303702 hasConcept C164705383 @default.
• W4367303702 hasConcept C167135981 @default.
• W4367303702 hasConcept C2777294900 @default.
• W4367303702 hasConcept C2777736543 @default.
• W4367303702 hasConcept C2778506911 @default.
• W4367303702 hasConcept C2780645631 @default.
• W4367303702 hasConcept C42219234 @default.
• W4367303702 hasConcept C519063684 @default.
• W4367303702 hasConcept C71924100 @default.
• W4367303702 hasConcept C78519656 @default.
• W4367303702 hasConceptScore W4367303702C126322002 @default.
• W4367303702 hasConceptScore W4367303702C127413603 @default.
• W4367303702 hasConceptScore W4367303702C164705383 @default.
• W4367303702 hasConceptScore W4367303702C167135981 @default.
• W4367303702 hasConceptScore W4367303702C2777294900 @default.
• W4367303702 hasConceptScore W4367303702C2777736543 @default.
• W4367303702 hasConceptScore W4367303702C2778506911 @default.
• W4367303702 hasConceptScore W4367303702C2780645631 @default.
• W4367303702 hasConceptScore W4367303702C42219234 @default.
• W4367303702 hasConceptScore W4367303702C519063684 @default.
• W4367303702 hasConceptScore W4367303702C71924100 @default.
• W4367303702 hasConceptScore W4367303702C78519656 @default.
• W4367303702 hasLocation W43673037021 @default.
• W4367303702 hasOpenAccess W4367303702 @default.
• W4367303702 hasPrimaryLocation W43673037021 @default.
• W4367303702 hasRelatedWork W1011510382 @default.
• W4367303702 hasRelatedWork W2018228973 @default.
• W4367303702 hasRelatedWork W2050367681 @default.
• W4367303702 hasRelatedWork W2053516909 @default.
• W4367303702 hasRelatedWork W2108064321 @default.
• W4367303702 hasRelatedWork W2562169712 @default.
• W4367303702 hasRelatedWork W2794442896 @default.
• W4367303702 hasRelatedWork W3207630000 @default.
• W4367303702 hasRelatedWork W4294023980 @default.
• W4367303702 hasRelatedWork W92685280 @default.
• W4367303702 isParatext "false" @default.
• W4367303702 isRetracted "false" @default.
• W4367303702 workType "article" @default.